Lyell Immunopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.

CEO

Lynn Seely

CEOLynn Seely

Employees

300

Employees300

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2018

Founded2018

Employees

300

Employees300

LYEL Key Statistics

Market cap

327.26M

Market cap327.26M

Price-Earnings ratio

-0.68

Price-Earnings ratio-0.68

Dividend yield

—

Dividend yield—

Average volume

28.63K

Average volume28.63K

High today

$17.04

High today$17.04

Low today

$16.60

Low today$16.60

Open price

$16.78

Open price$16.78

Volume

1.84K

Volume1.84K

52 Week high

$30.00

52 Week high$30.00

52 Week low

$7.65

52 Week low$7.65

LYEL News

TipRanks 3d

Lyell Immunopharma’s LYL314 Study: A Promising Step in Lymphoma Treatment

Lyell Immunopharma, Inc. ((LYEL)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

TipRanks 3d

Lyell Immunopharma’s New CAR T-Cell Therapy Trial: A Potential Game-Changer in Lymphoma Treatment?

Lyell Immunopharma, Inc. ((LYEL)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

People also own

Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.